Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab.

Kita, Aya

Sepantronium bromide (YM155) enhances response of human B-cell non-Hodgkin lymphoma to rituximab. [electronic resource] - The Journal of pharmacology and experimental therapeutics Oct 2012 - 178-83 p. digital

Publication Type: Journal Article

1521-0103

10.1124/jpet.112.195925 doi


Animals
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Drug Therapy, Combination
Female
Humans
Imidazoles--administration & dosage
Lymphoma, B-Cell--diagnostic imaging
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Mice, SCID
Naphthoquinones--administration & dosage
Radionuclide Imaging
Rituximab
Treatment Outcome
Xenograft Model Antitumor Assays--methods